本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Can-Fite Biopharma Ltd

2.33
+0.17007.87%
盤後2.330.00000.00%19:54 EDT
成交量:15.50萬
成交額:35.41萬
市值:499.21萬
市盈率:-0.50
高:2.37
開:2.17
低:2.16
收:2.16
52周最高:13.40
52周最低:2.16
股本:214.25萬
流通股本:214.25萬
量比:0.95
換手率:7.23%
股息:- -
股息率:- -
每股收益(TTM):-4.6460
每股收益(LYR):-1,791.0249
淨資產收益率:-211.37%
總資產收益率:-77.12%
市淨率:1.03
市盈率(LYR):0.00

資料載入中...

2019/04/04

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/02

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/02

[修訂]年度報告

[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/03/28

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/26

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/20

SEC問詢函

[Cover]Correspondence
2019/03/12

[修訂]招股説明書

[Amend] Registration statement for certain foreign private issuers
2019/03/11

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/04

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/25

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/04

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/01

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/30

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/24

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/24

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/22

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/18

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/08

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/10

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/10

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]